| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6199075 | Ophthalmology | 2016 | 9 Pages |
Abstract
Topical tacrolimus 0.05% is safe, generally well tolerated, and effective for the treatment of ocular GVHD without the hypertensive effects of topical corticosteroids.
Keywords
logMARGvHDOSDIMEEIhuman leukocyte antigen-DRtear film break-up timeTBUTCFSHSCTHLA-DRiOpcorneal fluorescein stainingICAM-1Graft-versus-host diseaseNEIOcular Surface Disease IndexIntraocular pressurelogarithm of the minimum angle of resolutionNational Eye Instituteintercellular adhesion molecule-1Hematopoietic stem cell transplantation
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Tulio B. MD, Francisco MD, MSc, Ujwala S. MD, Antonio MD, Thomas H. MD, Joseph B. MD, Pedram MD, Reza MD, MPH,